Puerarin

Specifications

3681-99-0CAS Number

609-296-1EC Number

7-hydroxy-3-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-oneIUPAC Name

C21H20O9Chemical Formula

416.4 g/molMolecular Weight

Puerarin; 3681-99-0; Kakonein; Daidzein-8-C-glucoside; Daidzein 8-c-glucoside; Puerarin 80 mm; CHEBI:8633; NPI 031G; DTXSID30958020; 7-hydroxy-3-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one; NSC-380711; Z9W8997416; 4H-1-Benzopyran-4-one, 8-beta-D-glucopyranosyl-7-hydroxy-3-(4-hydroxyphenyl)-; 7-hydroxy-3-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one; 7-hydroxy-3-(4-hydroxyphenyl)-8-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)chromen-4-one; 7-hydroxy-3-(4-hydroxyphenyl)-8-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl)chromen-4-one; RefChem:870306; DTXCID001385940; 7-hydroxy-3-(4-hydroxyphenyl)-8-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-4H-chromen-4-one; MFCD00063399; 7,4'-Dihydroxy-8-C-glucosylisoflavone; 8-(beta-D-Glucopyranosyl)-4',7-dihydroxyisoflavone; 8-beta-D-Glucopyranosyl-7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; Puerarin, analytical standard; 7-hydroxy-3-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4H-chromen-4-one; (1S)-1,5-anhydro-1-[7-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-8-yl]-D-glucitol; AC1NQZ4N; HKEAFJYKMMKDOR-VPRICQMDSA-N; UNII-Z9W8997416; 7-Hydroxy-3-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]-4H-chromen-4-one; Puerarin (Standard); NSC 380711; BRN 0064198; Puerarin, High Purity; PUERARIN [WHO-DD]; SureCN8581666; A1H6W; 4-19-00-03200 (Beilstein Handbook Reference); MLS002473178; BIDD:ER0101; CHEMBL486386; orb1304986; orb3139895; SCHEMBL8581666; SCHEMBL29642342; GTPL12553; HKEAFJYKMMKDOR-VPRICQMDSA-; HY-N0145R; HMS2198M10; Puerarin, >=98.0% (HPLC); 7-hydroxy-3-(4-hydroxyphenyl)-8-[(3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one; HY-N0145; MSK40127; BDBM50129558; EBC-11111; LMPK12050005; AKOS007930376; AKOS015965556; CS-6158; DB12290; KS-5191; MP08125; AC-20294; SMR001397270; SY075296; 7,4'-dihydroxyisoflavone-8-glucopyranoside; NS00018338; P8117; P8118; 4',7-DIHYDROXY-8-C-GLUCOSYLISOFLAVONE; F979488; 8-(|_-D-Glucopyranosyl)-4',7-dihydroxyisoflavone; 8-(|A-D-Glucopyranosyl)-4',7-dihydroxyisoflavone; BRD-K89048337-001-06-9; Q63408673; Z1494829516; 8-?-D-Glucopyranosyl-7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; (1S)-1,5-Anhydro-1-[7-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl]-D-glucitol; 4H-1-BENZOPYRAN-4-ONE, 8-.BETA.-D-GLUCOPYRANOSYL-7-HYDROXY-3-(4-HYDROXYPHENYL)-; InChI=1/C21H20O9/c22-7-14-17(26)18(27)19(28)21(30-14)15-13(24)6-5-11-16(25)12(8-29-20(11)15)9-1-3-10(23)4-2-9/h1-6,8,14,17-19,21-24,26-28H,7H2/t14-,17-,18+,19-,21+/m1/s1Synonyms